Drug profile · INN
nifurtimox
LAMPIT
nifurtimox (LAMPIT) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — nifurtimox
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nifurtimox (LAMPIT) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN nifurtimox
Brand LAMPIT
Mechanism DNA inhibitor
Target DNA
Route ORAL
Formulation TABLET
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nifurtimox?
nifurtimox (LAMPIT) is a dna inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nifurtimox?
LAMPIT is a marketed brand name for nifurtimox. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nifurtimox?
nifurtimox has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.